Virtu Financial LLC Adaptive Biotechnologies Corp Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	SELL	$3.46 - $5.33 $145,967 - $224,856	-42,187 Reduced 63.28%	24,475 $120,000
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $267,807 - $445,817	52,822 Added 381.66%	66,662 $363,000
Q2 2023 Jul 27, 2023	BUY	$6.19 - $8.78 $85,669 - $121,515	13,840 New	13,840 $93,000
Q4 2021 Feb 17, 2022	SELL	$25.17 - $36.85 $256,784 - $375,943	-10,202 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $306,264 - $406,753	10,202 New	10,202 $347,000
Q2 2021 Sep 17, 2021	SELL	$32.22 - $44.59 $469,735 - $650,077	-14,579 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$37.26 - $67.74 $302,476 - $549,913	8,118 Added 125.65%	14,579 $587,000
Q4 2020 Feb 24, 2021	BUY	$45.01 - $65.47 $290,809 - $423,001	6,461 New	6,461 $382,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.